NFKB1 and Duchenne muscular dystrophy: Treatment with the antioxidant N-acetylcysteine (NAC) inhibits its activation, suggesting that oxidative stress lies upstream of NF-κB and drives upregulation of NF-κB to contribute to the myopathy in DMD [51, 52].